Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease
about
Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascadeSignal Transduction in Astrocytes during Chronic or Acute Treatment with Drugs (SSRIs, Antibipolar Drugs, GABA-ergic Drugs, and Benzodiazepines) Ameliorating Mood DisordersDocosahexaenoic acid (DHA): an ancient nutrient for the modern human brainTransient postnatal fluoxetine leads to decreased brain arachidonic acid metabolism and cytochrome P450 4A in adult miceChronic SSRI stimulation of astrocytic 5-HT2B receptors change multiple gene expressions/editings and metabolism of glutamate, glucose and glycogen: a potential paradigm shift.The Use of Neuroimaging to Assess Associations Among Diet, Nutrients, Metabolic Syndrome, and Alzheimer's Disease.Rat brain docosahexaenoic acid metabolism is not altered by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide.Blocking of carnitine palmitoyl transferase 1 potently reduces stress-induced depression in rat highlighting a pivotal role of lipid metabolismBrain arachidonic acid cascade enzymes are upregulated in a rat model of unilateral Parkinson diseaseCoordination of gene expression of arachidonic and docosahexaenoic acid cascade enzymes during human brain development and aging.RETRACTED: Dose-dependent changes in neuroinflammatory and arachidonic acid cascade markers with synaptic marker loss in rat lipopolysaccharide infusion model of neuroinflammationShort-term long chain omega3 diet protects from neuroinflammatory processes and memory impairment in aged mice.Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review.Fluoxetine and all other SSRIs are 5-HT2B Agonists - Importance for their Therapeutic Effects.Dietary n-6 PUFA deprivation downregulates arachidonate but upregulates docosahexaenoate metabolizing enzymes in rat brain.Cyclooxygenases and 5-lipoxygenase in Alzheimer's disease.Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma.Chronic dietary n-6 PUFA deprivation leads to conservation of arachidonic acid and more rapid loss of DHA in rat brain phospholipids.Increasing dietary linoleic acid does not increase tissue arachidonic acid content in adults consuming Western-type diets: a systematic review.iPLA2β knockout mouse, a genetic model for progressive human motor disorders, develops age-related neuropathology.Regulation of rat brain polyunsaturated fatty acid (PUFA) metabolism during graded dietary n-3 PUFA deprivation.Balancing the benefits of n-3 polyunsaturated fatty acids and the risks of methylmercury exposure from fish consumption.Coordinated Expression of Phosphoinositide Metabolic Genes during Development and Aging of Human Dorsolateral Prefrontal CortexImaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans.Dietary n-6 polyunsaturated fatty acid deprivation increases docosahexaenoic acid metabolism in rat brain.Transient postnatal fluoxetine decreases brain concentrations of 20-HETE and 15-epi-LXA4, arachidonic acid metabolites in adult mice.Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega-3 plasma concentrations are altered by treatment.Translational studies on regulation of brain docosahexaenoic acid (DHA) metabolism in vivo.Elevated immune-inflammatory signaling in mood disorders: a new therapeutic target?Chronic clozapine reduces rat brain arachidonic acid metabolism by reducing plasma arachidonic acid availability.Propylisopropylacetic acid (PIA), a constitutional isomer of valproic acid, uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: a potential drug for bipolar disorderDietary omega-3 polyunsaturated fatty acids improve the neurolipidome and restore the DHA status while promoting functional recovery after experimental spinal cord injuryPhospholipases A2 and inflammatory responses in the central nervous system.Therapeutic use of omega-3 fatty acids in bipolar disorder.Dietary lipids and their oxidized products in Alzheimer's disease.Pharmacological approaches for Alzheimer's disease: neurotransmitter as drug targets.Reconsidering Dietary Polyunsaturated Fatty Acids in Bipolar Disorder: A Translational Picture.Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of {omega}-3 fatty acidsMetabolic links between diabetes and Alzheimer's disease.Kinetics of eicosapentaenoic acid in brain, heart and liver of conscious rats fed a high n-3 PUFA containing diet.
P2860
Q26850084-0773C69A-17E8-488A-8F72-A81E26468EFEQ27006485-9AEB6F8A-0B07-40B6-8865-1DD74E37E5AEQ28732836-E6C44996-B7F9-4155-930F-EEC39DAFAF46Q30575789-5E3DEF28-F975-442F-9ED2-759487FA32A8Q30906677-A5492238-8B2B-4A95-A738-550E77A09210Q30996713-0B2F7472-7D3E-499C-A29E-E7DC97735D8EQ33689487-C60CEDB6-0793-4087-A9D4-95BA24F7E7A0Q33708579-83CEFD6A-DE05-4961-85C9-98D1DB9394E3Q33718730-BDB4610C-E423-4513-8339-A4490F020C7FQ33806815-FA751ACB-30C9-4F29-BA27-21CA1E74A400Q34279077-F6F2823A-6B60-4F19-92DA-42691FA93277Q34290929-0802FBF1-2074-4046-B1CB-35DD767F40F1Q34384181-AE3183AA-478D-4A60-872E-E89CB4C391E9Q34391633-E450175C-BAE8-4D04-84F2-F09FD2E81276Q34478836-DA57ACCE-FDD4-41EA-85CF-7AB4CFBCBBA6Q34551101-EF7F2F6C-E8E1-4F03-916F-DC69CBF8FD25Q34559890-B02F0400-23EB-4042-A8D7-BFAFC16FE5A4Q35014292-29CBCE9C-CD00-4B24-A016-13998BEE7B36Q35094813-F9A1D48E-093E-405B-A50D-103CE75736F1Q35189288-E34289E8-F516-4408-820B-0D4001FDD22DQ35529104-F0C830AB-8D6E-436A-B98E-B4916DBB372EQ35559726-6C43DE2C-4B56-493F-BF1C-45318FC56602Q35689659-77DF629D-11AB-4411-B43D-56D425E26D26Q35742545-6E9EDAA9-A2B4-434A-91C3-8BB303AAF0E2Q35812881-CE5AA88C-1528-4B1D-975B-7B193A76A819Q36090348-3140AAF2-2E6B-43D9-97A3-2F51974E6B97Q36217965-31E88BEC-7175-43D2-B889-C4E9E846D420Q36306413-CF54D1EF-3EB1-4440-AFCD-958EDE279B30Q36502629-8F4AED62-9344-46B3-96EE-BF7BA53DE16AQ36518167-20EB4CFD-3750-4A42-B218-6C460D74EEB7Q36673587-FC10C8EE-AC97-48BF-86AC-6990C5C0B6B3Q36862989-962DA194-EE03-4828-AB27-1B45B118D542Q37621283-DE90489B-AA9E-4107-BDA5-51864CD474AFQ37896631-6ECD5593-682F-4C7E-800B-50359E49B3EFQ37939806-5DFAF7CD-E0E5-4751-A9A1-F48F4B3645FEQ38286222-D3B04A52-9DC7-4DD4-827F-FC9F027972F6Q38804214-3A5B5030-3672-4A17-9EA2-13EC62971444Q42108073-6D63C600-A227-4B9F-9A91-668B983AB911Q46032053-9589FBEC-9A96-4CA4-9913-CC9EA8ABCCDDQ48883388-79A402F0-4E71-4A66-B1BA-A155FE867FD4
P2860
Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Brain arachidonic and docosahe ...... red by drugs, diet and disease
@ast
Brain arachidonic and docosahe ...... red by drugs, diet and disease
@en
type
label
Brain arachidonic and docosahe ...... red by drugs, diet and disease
@ast
Brain arachidonic and docosahe ...... red by drugs, diet and disease
@en
prefLabel
Brain arachidonic and docosahe ...... red by drugs, diet and disease
@ast
Brain arachidonic and docosahe ...... red by drugs, diet and disease
@en
P2860
P1476
Brain arachidonic and docosahe ...... red by drugs, diet and disease
@en
P2860
P304
P356
10.1016/J.PLEFA.2008.09.010
P577
2008-09-01T00:00:00Z